Enlivex Ltd. (ENLV)
Nasdaq: ENLV · Pharmaceutical Preparations · Tel Aviv · filing with the SEC since 2014
Who runs Enlivex Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Hershkovitz Oren
Chief Executive Officer. First filing Mar 2026, latest Mar 18, 2026, 0 filings in all.
Officers reporting now
3
of 7 people with a filing in the last fifteen months
Directors reporting now
4
7 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Hershkovitz Oren | Chief Executive Officer | Mar 2026 | Mar 18, 2026 | none |
| Shlosberger Shachar | Chief Financial Officer | Mar 2026 | Mar 18, 2026 | none |
| Galamidi Einat | Chief Medical Officer | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Hart Gili | director | Mar 2026 | Mar 18, 2026 | none |
| Havron Avraham | director | Mar 2026 | Mar 18, 2026 | none |
| Novik Shai A | director | Mar 2026 | Mar 18, 2026 | none |
| Pomerantz Roger | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.